Vimarsana
Biggest News Aggregation in the World

Page 2 - Aktx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aktx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aktx Today - Breaking & Trending Today

Akari Therapeutics (NASDAQ:AKTX) Receives New Coverage from Analysts at StockNews.com - Vimarsana News

Akari Therapeutics (NASDAQ:AKTX) Receives New Coverage from Analysts at StockNews.com

Stock analysts at StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Free Report) in a report released on Friday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Akari Therapeutics Trading Down 13.6 % NASDAQ:AKTX opened at $2.60 on Friday. The company’s 50 day moving average price is $3.01 and […]

Short Interest in Akari Therapeutics, Plc (NASDAQ:AKTX) Drops By 50.0% - Vimarsana News

Short Interest in Akari Therapeutics, Plc (NASDAQ:AKTX) Drops By 50.0%

Akari Therapeutics, Plc (NASDAQ:AKTX – Get Free Report) saw a large decrease in short interest in December. As of December 15th, there was short interest totalling 1,700 shares, a decrease of 50.0% from the November 30th total of 3,400 shares. Based on an average daily volume of 12,000 shares, the days-to-cover ratio is currently 0.1 […]

Akari Therapeutics (NASDAQ:AKTX) Research Coverage Started at StockNews.com - Vimarsana News

Akari Therapeutics (NASDAQ:AKTX) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a research note released on Monday. The firm issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Price Performance Shares of Akari Therapeutics stock opened at $2.96 on Monday. The stock has a 50-day moving average price of $3.26 and […]

Source: wkrb13.com
Akari Therapeutics (NASDAQ:AKTX) Now Covered by StockNews.com - Vimarsana News

Akari Therapeutics (NASDAQ:AKTX) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a research note issued to investors on Monday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Trading Up 1.4 % Shares of NASDAQ:AKTX opened at $2.84 on Monday. Akari Therapeutics has a 1 year low of […]

Akari Therapeutics (NASDAQ:AKTX) Coverage Initiated by Analysts at StockNews.com - Vimarsana News

Akari Therapeutics (NASDAQ:AKTX) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a research note released on Friday. The firm issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Performance Shares of AKTX stock opened at $2.91 on Friday. The firm has a fifty day simple moving average of $3.51 and […]